Halina B. P.
- Country
- Poland
- Department
- NA
Research Overview
- Long-term Safety and Efficacy Assessment of Intravenous Cipaglucosidase Alfa Co-administered with Oral Miglustat in Adults with Late-onset Pompe Disease
- Phase III Randomized, Double-Blind, Placebo-Controlled Study of Iptacopan in Patients with Generalized Myasthenia Gravis
- Efficacy and Safety Evaluation of Riliprubart in Refractory Chronic Inflammatory Demyelinating Polyneuropathy: A Phase 3 Double-Blind, Placebo-Controlled Study
Data & Insights
Has run more than one trial at 190 of 369 partner sites.
Specializations
Inflammatory Bowel Disease
Clinical research activity includes ulcerative colitis and Crohn’s disease, with attention to both induction and maintenance treatment strategies, as well as more complex disease patterns such as fistulizing perianal Crohn’s disease.
- Moderately to severely active ulcerative colitis
- Moderately to severely active Crohn’s disease
- Fistulizing perianal Crohn’s disease
Therapeutic interests also extend to biosimilar therapy and advanced biologic approaches in chronic intestinal inflammation.
Cardiovascular Medicine
The investigator is involved in studies addressing atherosclerotic cardiovascular disease, atrial fibrillation, heart failure, and broader cardiovascular risk reduction, including patients with metabolic comorbidity.
- Atherosclerotic cardiovascular disease
- Atrial fibrillation
- Heart failure
Additional focus areas include lipid lowering, hypertension, and prevention of major adverse cardiovascular events.
Neurology and Neuroimmunology
Research involvement covers multiple sclerosis across progressive and relapsing forms, along with other immune-mediated neurological disorders such as chronic inflammatory demyelinating polyneuropathy and myelin oligodendrocyte glycoprotein antibody-associated disease.
- Multiple sclerosis
- Chronic inflammatory demyelinating polyneuropathy
- Myelin oligodendrocyte glycoprotein antibody-associated disease
Therapeutic activity also includes evaluation of disease-modifying treatment options in progressive neurological disability.
Nephrology and Metabolic Disease
Clinical work includes chronic kidney disease, high proteinuria, and kidney-related complications in patients with type 2 diabetes and hypertension, together with studies in obesity and dyslipidemia.
- Chronic kidney disease
- High proteinuria
- Obesity and dyslipidemia
Interest also extends to non-alcoholic steatohepatitis and kidney-cardiometabolic overlap.
Oncology, Endocrinology, and Rare Disorders
The investigator is active in trials spanning breast cancer, prostate cancer, renal cell carcinoma, and hematologic malignancies, alongside endocrine and rare disease areas such as type 1 diabetes, growth disorders, and Pompe disease.
- Breast cancer
- Prostate cancer
- Rare endocrine and metabolic disorders
Therapeutic engagement also includes bone fragility disorders, autoimmune disease, and selected pediatric conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.